Novartis and dHealth, together with the University of Basel and the Swiss TPH—partnered to develop a COVID-19 module that would assist with tracking and subduing SARS-CoV-2 outbreaks.
Novartis and dHealth developed a COVID-19 module intended to be used to track COVID-19 outbreaks. It gathers users’ symptoms, provides recommendations on how to respond to them, and more.
The app has been designed to utilize positive COVID-19 diagnoses at point-of-care to immediately inform all recent contacts of the patients positively diagnosed with COVID-19 so that they can self-isolate, and monitor their symptoms remotely via daily questionnaires.
This feat was accomplished through a Private-Public Partnership (PPP) with two other partners—the University of Basel and the Swiss Tropical and Public Health Institute (Swiss TPH).
Since the pandemic's end, the developed module's initial purpose has been defunct. However, it can easily be appropriated for other diseases—which is the current goal of the dHealth team.